Beth Mole
Author ProfileClaim This Author Profile
Prove ownership by publishing #HashtagPLUS and this profile link on your author page or an article under your byline. A moderator or admin will review the request before it merges into your real HashtagPLUS username.
🌐 arstechnica.comSource
Trust is slow to build and quick to lose," board chair Jack Leslie said.
🌐 arstechnica.comSource
The departure comes amid turmoil in Kennedy's Make America Healthy Again movement.
🌐 arstechnica.comSource
Markers released top-line results today after previously reporting the trial succeeded.
🌐 arstechnica.comSource
The decried trial was canceled last week before police seized vaccine doses.
🌐 arstechnica.comSource
Guinea-Bissau police said hepatitis B vaccine doses were taken as part of an investigation.
🌐 arstechnica.comSource
About 1 in 5 cases were hospitalized and most of those developed complications.
🌐 arstechnica.comSource
The US has previously built specialized facilities just for this purpose.
🌐 arstechnica.comSource
The interim Phase I trial data was only from 35 people, but results look good so far.
🌐 arstechnica.comSource
There are strategies to improve healthcare, but US isn't trying them.